|
Post by derek2 on Dec 15, 2015 16:05:12 GMT -5
There's an article released under SA Pro that is not visible to the public yet. You can see reference to it on George Rho's profile page at: seekingalpha.com/author/george-rho/commentsActually we can get a hint of the content from George's reply to a comment on the article: George's comment: It would appear to me that George is no longer cheerleader #1, but the tone could be because of the tone of the unseen comment that he's responding to. I would say, though, that if George Rho turns bearish, it'll be a clear sign of capitulation, and would be a signal to look at the stock as a possible contrarian trade, having been oversold. I do not see this comment as George being bearish. Not at all. He is saying that MannKind have more than enough money in hand, that Sanofi need time to do their job in securing preferred insurance status for Afrezza and that massive advertising now is unwise. I completely agree and I am adding shares. As I pointed out, I really don't have enough context to say one way or the other, although another post over on YMB (made after I posted here) seems to show that George is still quite optimistic:
|
|
|
Post by kball on Dec 15, 2015 16:07:04 GMT -5
"i want some of what you are having" The request was for George Rho Dec article. As you can see it isn't about Afrezza. The original poster was misinformed. Why you would repost the whole article is something I don't understand. Maybe I can have some of what you are having? There's an article released under SA Pro that is not visible to the public yet. You can see reference to it on George Rho's profile page at: seekingalpha.com/author/george-rho/commentsActually we can get a hint of the content from George's reply to a comment on the article: George's comment: It would appear to me that George is no longer cheerleader #1, but the tone could be because of the tone of the unseen comment that he's responding to. I would say, though, that if George Rho turns bearish, it'll be a clear sign of capitulation, and would be a signal to look at the stock as a possible contrarian trade, having been oversold. Pretty safe to call it a contrarian trade now.
|
|
|
Post by thekindaguyiyam on Dec 15, 2015 16:13:38 GMT -5
There's an article released under SA Pro that is not visible to the public yet. You can see reference to it on George Rho's profile page at: seekingalpha.com/author/george-rho/commentsActually we can get a hint of the content from George's reply to a comment on the article: George's comment: It would appear to me that George is no longer cheerleader #1, but the tone could be because of the tone of the unseen comment that he's responding to. I would say, though, that if George Rho turns bearish, it'll be a clear sign of capitulation, and would be a signal to look at the stock as a possible contrarian trade, having been oversold. "Pretty safe to call it a contrarian trade now." If I'm not mistaken, this has been your view for much much longer than "now" kball
|
|
|
Post by silentknight on Dec 15, 2015 16:29:22 GMT -5
For further reading, check out the new article on Seeking Alpha regarding Mannkind's Weekly Data. The author details the the launch of Sanofi's drug Praluent, where it received preferred coverage from insurers in four (4) months after FDA approval. FOUR MONTHS. That is clear evidence that SNY can and will move quickly to market a drug when they see fit and has neglected to market Afrezza as they promised to likely intentionally starve the drug and Mannkind of the resources and effort needed to ensure Afrezza's success. I'm sure people will say that you can't compare the two as all drugs are different, etc.... but that's nonsense. This shows that when committed, the wheels of SNY turn quickly when it's in their interest.
They haven't improved doctor education or insurance coverage for Afrezza to my knowledge. We are seeing stagnant script growth and worsening insurance coverage according to many posters here. Why? If they can achieve preferred status for their own drug in four months, what have we to show for 15 months since the partnership? The burden of proof in a lawsuit is the preponderance of the evidence and the circumstantial type is powerful and admitted. At this point, it's more likely than not that they've organized an effort against MNKD. Any objectivity at all points to signs that thus far it's been feet dragging by MNKD's partner. Time to follow in Genzyme's footsteps in my opinion.
Sorry to rant, but the new information (at least to me) about Praluent gave me all the information I needed about what the problem as been all along.
|
|
|
Post by _neil on Dec 15, 2015 16:58:10 GMT -5
The failure of Afrezza is doubtless a marketing snafu. But putting it on SNY's doorstep is a mistake. In hindsight, whoever put together the terms in the agreement with MNKD is a genius. They must've known the people from MNKD were suckers. I'm no lawyer but I think MNKD shareholders are left without any options since clearly, all operations were done through a 50-50 board comprising the people from MNKD. Investing in MNKD was sowing crap. We're left to reap what comes of it
|
|
|
Post by thekindaguyiyam on Dec 15, 2015 17:07:50 GMT -5
-neil did you not write this? and if you did... are you here just to vent some more? Yep more layoffs Oct 1, 2015 at 2:09pm Quote like Post Options Post by _neil on Oct 1, 2015 at 2:09pm harrys Avatar Oct 1, 2015 at 8:01am harrys said: nemzter Avatar Oct 1, 2015 at 7:54am nemzter said: Is $15 too much to ask for? "Al, make it happen!!! LOL I wish we could have a serious discussion on what we think Al would or could take the company private for, based on past experience investing? or experience in the private sector? $5 is my break even and considering the lack of opportunity cost in the broader market in the timeframe I've been invested, I wouldn't stand in Al's way if he went for >$5. I'll wash my hands off this trainwreck for 4.50$ If the tiny sample size of this board is able to price MNKD at 4.50, imagine what the real market will do to this company? I throw in my towel today. There is no redemption for this stock or the company. As far as I am concerned, Al Mann stole my money." Read more: mnkd.proboards.com/user/703/recent#ixzz3uQhcDG2m
|
|
|
Post by liane on Dec 15, 2015 17:45:43 GMT -5
I removed the George Rho articles that were printed in their entirety - you're violating the copyright.
|
|
|
Post by greg on Dec 15, 2015 17:48:35 GMT -5
Just for the record, the article that was deleted a few seconds ago, supposedly authored by George Rho, is not the genuine article. Shame on whoever posted it.
|
|
|
Post by thekindaguyiyam on Dec 15, 2015 17:49:10 GMT -5
thanks for the explanation Liane. I won't copy from Seeking Alpha again. Other's have posted articles; but I'll respect your lead.
|
|
|
Post by greg on Dec 15, 2015 17:52:26 GMT -5
thanks for the explanation Liane. I won't copy from Seeking Alpha again. Other's have posted articles; but I'll respect your lead. thekindaguyiyam, It wasn't even a George Rho article so why would you post it as such?
|
|
|
Post by thekindaguyiyam on Dec 15, 2015 17:55:44 GMT -5
they were both copy and past from seeking alpha. I don't know what you are looking at. I post what's real; I don't make things up... that is a characteristic of the other side.
|
|
|
Post by greg on Dec 15, 2015 17:59:54 GMT -5
they were both copy and past from seeking alpha. I don't know what you are looking at. I post what's real; I don't make things up... that is a characteristic of the other side. Deliberate or not, it was not the article published by George this morning. The one you posted had a whole bunch of jumbled up data, scripts, I believe, and George's doesn't.
|
|
|
Post by thekindaguyiyam on Dec 15, 2015 18:12:09 GMT -5
you are mistaken greg.
In my introduction I stated that the data didn't align in the paste. Non the less; it was inappropriate of me to post a copy written piece. both were articles from George Rho who I deeply respect.
|
|
|
Post by EveningOfTheDay on Dec 15, 2015 18:24:50 GMT -5
I am sorry Iyam, but you are wrong. George only published one article today in SA. It was supposed to be public, but apparently, George told me, won a contest and was diverted to SA Pro for 30 days. The article that you publish is the rubbish that Looking for Diogenes post weekly on Afrezza scripts. If you do not believe me please check it out, but the article you copy and posted was not authored by George Rho, who, by the way, is still optimistic on the long term outlook of Afrezza.
|
|
|
Post by greg on Dec 15, 2015 18:25:36 GMT -5
you are mistaken greg. In my introduction I stated that the data didn't align in the paste. Non the less; it was inappropriate of me to post a copy written piece. both were articles from George Rho who I deeply respect. I am not mistaken. The data was not from any article ever published by George. Neither was the rest of the article. I don't know why you did what you did, but I do know that the article you posted had a negative tilt. Forgive me for being cynical but there's just so much crapola coming from the other side.
|
|